Otsuka Holdings Co., Ltd. (Otsuka Holdings) is a corporation located at 2-9 Kanda Tsukacho, Chiyoda-ku, Tokyo, where Higuchi Tatsuo, founded in July 2008 serves as president and representative (corporate number: 4010001118786). The final registration was updated on October 5, 2015, and a new establishment (corporate number registration) was carried out.
Otsuka Lifestyle OTSUKA-SEIKATSU and other trademarks have been registered. White company information is currently being posted.
The financial results for the fiscal year ending December 2024 (revenue: 2.329.861 trillion yen, net income: 343.12 billion yen) . Kaisha's reputation is rated 64/100 on review sites by employees and former employees.
There is no legal violation/disposition/black information posted.
Company Profile
| Corporate number | 4010001118786 |
|---|---|
| Corporate name | Otsuka Holdings Co., Ltd. |
| Furigana | Otsuka Holdings |
| Address/Map | 〒101-0048 2-9 Kanda Tsukacho, Chiyoda-ku, Tokyo |
| Stock code | 4578 |
| President/Representative | Chairman of the Board of Directors Otsuka Ichiro President and CEO Inoue Makoto Representative Director and Vice President Matsuo Director Takagi Shuichi Director Kobayashi Masayuki Director Tojo Noriko |
| URL | https://www.otsuka.com/ |
| telephone number | 03-6717-1410 |
| Establishment | July 8, 2008 |
| Industry | manufacturing industry |
| Corporate number designation date | 2015/10/05 |
| Last registration update date | 2015/10/05 |
Press releases and advertisements from Otsuka Holdings Co., Ltd.
Currently, there are no press release articles from Otsuka Holdings Co., Ltd.
About Otsuka Holdings Co., Ltd.
Since its founding in 1921, Otsuka Holdings Co., Ltd. has continued to grow as a total healthcare company under the unwavering corporate philosophy of "making people around the world healthy." He is responsible for everything from daily health maintenance and promotion to diagnosis and treatment of diseases, and contributes to the health of people around the world by providing original products in his medical and neutrals related businesses.
"What Otsuka can do" and "What Otsuka can do"
With this thought in mind, each employee makes the most of the strengths they have cultivated throughout the group, and not only the apparent needs, but also the consumers are not aware of this yet, with these feelings being made available to them. We strive to develop innovative products and services in order to meet our needs.
From Tokushima Prefecture, the home of its founding to meet diversifying healthcare needs,
The Otsuka Group has grown by providing a diverse scientifically based products and services to all healthcare needs that are desired in the era and region. We are constantly looking ahead and looking ahead, looking ahead.
and
development, and establishing solid brands. This brand fostering ability supports Otsuka's sustainable growth and increased corporate value, allowing us to challenge new healthcare needs with a unique approach.
Strengthening Group Management through a Holding Company System
From 2008, the group was moved to a holding company system, and by taking all major group companies under its umbrella, the group's management was strengthened. In December 2010, it was listed on the First Section of the Tokyo Stock Exchange.
With an eye on the future,
Otsuka Holdings Co., Ltd. continues to strive tirelessly to contribute to the health of people around the world, and continues to evolve.
Otsuka Holdings Co., Ltd. financial history (million yen)
| year | quarter | Submission date | sales revenue | Operating profit | Ordinary profit | Net income | Comprehensive income for the period |
|---|---|---|---|---|---|---|---|
| ending March 2013 | 2Q results | 2013/11/13 | 599,007 | 93,435 | 95,498 | 62,653 | 62,281 |
| 3Q results | 2014/02/13 | 892,563 | 131,414 | 140,848 | 91,196 | 91,529 | |
| Full-year results | 2014/05/14 | 1,218,055 | 169,660 | 184,462 | 122,429 | 151,737 | |
| ending March 2014 | 1Q results | 2014/08/08 | 323,526 | 50,544 | 56,821 | 39,703 | 57,049 |
| 2Q results | 2013/11/13 | 699,411 | 111,720 | 121,987 | 87,016 | 118,398 | |
| 3Q results | 2014/02/13 | 1,077,633 | 185,491 | 203,046 | 142,831 | 174,313 | |
| Full year revision | 2014/02/13 | 1,435,000 | 215,000 | 225,000 | 155,000 | – | |
| Full-year results | 2014/05/14 | 1,452,759 | 198,702 | 215,235 | 150,989 | 212,870 | |
Consolidated December 2014 * 9 months | 1Q results | 2014/08/08 | 386,344 | 65,565 | 69,482 | 45,246 | 37,799 |
| 2Q forecast | 2014/05/14 | 795,000 | 120,000 | 125,000 | 83,000 | – | |
| 2Q results | 2014/11/13 | 788,283 | 136,650 | 148,124 | 99,503 | 116,798 | |
| Full year forecast | 2014/05/14 | 1,200,000 | 190,000 | 195,000 | 130,000 | – | |
| Full-year results | 2015/02/13 | 1,224,298 | 196,528 | 217,210 | 143,143 | 197,603 | |
Consolidated for December 2015 | 1Q results | 2015/05/13 | 385,079 | 51,586 | 51,474 | 33,960 | 29,446 |
| 2Q forecast | 2015/02/13 | 710,000 | 55,000 | 60,000 | 40,000 | – | |
| 2Q correction | 2015/07/30 | 745,000 | 100,000 | 105,000 | 65,000 | – | |
| 2Q results | 2015/08/07 | 745,804 | 103,159 | 109,382 | 69,474 | 88,022 | |
| 3Q results | 2015/11/13 | 1,107,150 | 147,059 | 155,255 | 103,130 | 88,759 | |
| Full year forecast | 2015/02/13 | 1,370,000 | 110,000 | 120,000 | 80,000 | – | |
| Full year revision | 2015/08/07 | 1,380,000 | 120,000 | 125,000 | 80,000 | – | |
| Full year revision | 2015/11/13 | 1,410,000 | 145,000 | 150,000 | 90,000 | – | |
| Full-year results | 2016/02/12 | 1,445,227 | 151,837 | 159,899 | 84,086 | 72,319 | |
Consolidated for December 2016 | 1Q results | 2016/05/13 | 282,580 | 26,762 | 27,285 | 18,642 | -25,605 |
| 2Q forecast | 2016/02/12 | 608,000 | 25,000 | 30,000 | 20,000 | – | |
| 2Q correction | 2016/07/29 | 590,000 | 65,000 | 65,000 | 45,000 | – | |
| 2Q results | 2016/08/09 | 594,754 | 66,170 | 65,388 | 46,722 | -65,540 | |
| 3Q results | 2016/11/11 | 902,797 | 113,579 | 116,128 | 90,598 | -35,173 | |
| Full year forecast | 2016/02/12 | 1,250,000 | 70,000 | 80,000 | 50,000 | – | |
| Full year revision | 2016/08/09 | 1,200,000 | 100,000 | 100,000 | 75,000 | – | |
| Full year revision | 2016/11/11 | 1,200,000 | 115,000 | 115,000 | 85,000 | – | |
| Full-year results | 2017/02/14 | 1,195,547 | 101,145 | – | 92,563 | 64,627 | |
Consolidated for December 2017 | 1Q results | 2017/05/12 | 280,192 | 30,167 | – | 21,012 | -48 |
| 2Q forecast | 2017/02/14 | 605,000 | 58,000 | – | 42,000 | – | |
| 2Q results | 2017/08/08 | 595,361 | 49,506 | – | 42,426 | 32,920 | |
| 3Q results | 2017/11/14 | 919,022 | 94,885 | – | 73,064 | 79,225 | |
| Full year forecast | 2017/02/14 | 1,260,000 | 120,000 | – | 85,000 | – | |
| Full year revision | 2018/02/08 | 1,240,000 | 104,000 | – | 112,000 | – | |
| Full-year results | 2018/02/14 | 1,239,952 | 104,181 | – | 112,492 | 137,835 | |
Consolidated for December 2018 | 1Q results | 2018/05/11 | 294,650 | 34,769 | – | 22,726 | -23,795 |
| 2Q forecast | 2018/02/14 | 620,000 | 60,000 | – | 46,000 | – | |
| 2Q correction | 2018/07/31 | 618,000 | 78,000 | – | 63,000 | – | |
| 2Q results | 2018/08/08 | 618,325 | 78,309 | – | 63,876 | 25,438 | |
| 3Q results | 2018/11/14 | 948,074 | 96,750 | – | 77,678 | 74,832 | |
| Full year forecast | 2018/02/14 | 1,300,000 | 140,000 | – | 105,000 | – | |
| Full year revision | 2018/08/08 | 1,300,000 | 145,000 | – | 115,000 | – | |
| Full year revision | 2018/11/14 | 1,290,000 | 127,000 | – | 100,000 | – | |
| Full-year results | 2019/02/13 | 1,291,981 | 108,304 | – | 82,492 | 36,877 | |
Consolidated for December 2019 | 1Q results | 2019/05/14 | 313,956 | 31,203 | – | 19,152 | 31,046 |
| 2Q forecast | 2019/02/13 | 665,000 | 78,000 | – | 60,000 | – | |
| 2Q correction | 2019/07/30 | 670,000 | 96,000 | – | 67,000 | – | |
| 2Q results | 2019/08/08 | 671,131 | 96,524 | – | 67,763 | 44,886 | |
| 3Q results | 2019/11/12 | 1,028,758 | 155,830 | – | 111,519 | 80,467 | |
| Full year forecast | 2019/02/13 | 1,390,000 | 150,000 | – | 110,000 | – | |
| Full year revision | 2019/08/08 | 1,400,000 | 174,000 | – | 125,000 | – | |
| Full-year results | 2020/02/14 | 1,396,240 | 176,585 | – | 127,151 | 118,754 | |
Consolidated for December 2020 | 1Q results | 2020/05/28 | 339,560 | 53,946 | – | 37,710 | 4,421 |
| 2Q forecast | 2020/02/14 | 700,000 | 105,000 | – | 78,000 | – | |
| 2Q results | 2020/08/07 | 695,443 | 118,008 | – | 86,810 | 67,595 | |
| 3Q results | 2020/11/13 | 1,066,959 | 171,695 | – | 127,766 | 114,354 | |
| Full year forecast | 2020/02/14 | 1,445,000 | 197,000 | – | 145,000 | – | |
| Full year revision | 2020/08/07 | 1,410,000 | 202,000 | – | 150,000 | – | |
| Full year revision | 2020/11/13 | 1,420,000 | 203,000 | – | 150,000 | – | |
| Full-year results | 2021/02/12 | 1,422,826 | 198,582 | – | 148,137 | 142,590 | |
| ending December 2021 | 1Q results | 2021/05/13 | 336,789 | 50,092 | – | 44,682 | 102,474 |
| 2Q forecast | 2021/02/12 | 690,000 | 100,000 | – | 76,000 | – | |
| 2Q results | 2021/08/06 | 718,815 | 111,169 | – | 91,407 | 144,610 | |
| 3Q results | 2021/11/12 | 1,107,417 | 158,130 | – | 126,648 | 189,671 | |
| Full year forecast | 2021/02/12 | 1,423,000 | 192,000 | – | 146,000 | – | |
| Full year revision | 2021/08/06 | 1,480,000 | 208,000 | – | 165,000 | – | |
| Full year revision | 2021/11/12 | 1,480,000 | 203,000 | – | 161,000 | – | |
| Full year revision | 2022/01/27 | 154,000 | – | – | 125,000 | – | |
| Full-year results | 2022/02/10 | 1,498,276 | 154,497 | – | 125,463 | 217,267 | |
| ending December 2022 | 1Q results | 2022/05/13 | 380,308 | 20,749 | – | 23,255 | 86,686 |
| 2Q forecast | 2022/02/10 | 767,000 | 112,500 | – | 86,000 | – | |
| 2Q correction | 2022/07/26 | 814,000 | 67,000 | – | 69,800 | – | |
| 2Q results | 2022/07/29 | 814,307 | 67,146 | – | 69,753 | 244,712 | |
| 3Q results | 2022/10/31 | 1,266,119 | 114,848 | – | 111,030 | 344,361 | |
| Full year forecast | 2022/02/10 | 1,550,000 | 192,000 | – | 146,000 | – | |
| Full year revision | 2022/07/29 | 1,670,000 | 152,000 | – | 135,000 | – | |
| Full year revision | 2022/10/31 | 1,710,000 | 142,000 | – | 131,000 | – | |
| Full-year results | 2023/02/14 | 1,737,998 | 150,323 | – | 134,019 | 272,360 | |
| ending December 2023 | 1Q results | 2023/05/12 | 448,344 | 76,779 | – | 61,430 | 84,171 |
| 2Q forecast | 2023/02/14 | 867,000 | 91,500 | – | 68,000 | – | |
| 2Q correction | 2023/07/25 | 947,500 | 130,500 | – | 102,500 | – | |
| 2Q results | 2023/07/31 | 947,537 | 130,690 | – | 102,594 | 232,387 | |
| 3Q results | 2023/10/31 | 1,479,080 | 202,650 | – | 161,713 | 316,787 | |
| Full year forecast | 2023/02/14 | 1,800,000 | 210,000 | – | 157,500 | – | |
| Full year revision | 2023/07/31 | 1,905,000 | 245,000 | – | 188,000 | – | |
| Full year revision | 2023/10/31 | 1,985,000 | 245,000 | – | 188,000 | – | |
| Full year revision | 2024/02/13 | 2,018,000 | 139,000 | – | 121,000 | – | |
| Full-year results | 2024/02/14 | 2,018,568 | 139,612 | – | 121,616 | 227,764 | |
| ending December 2024 | 1Q results | 2024/04/30 | 519,517 | 92,021 | – | 77,377 | 152,511 |
| 2Q forecast | 2024/02/14 | 1,037,000 | 168,000 | – | 126,000 | – | |
| 2Q correction | 2024/05/22 | 1,100,000 | 95,000 | – | 74,000 | – | |
| 2Q correction | 2024/07/26 | 1,108,000 | 126,000 | – | 107,000 | – | |
| 2Q results | 2024/08/01 | 1,108,930 | 126,279 | – | 107,795 | 264,541 | |
| 3Q results | 2024/10/31 | 1,730,076 | 261,045 | – | 191,672 | 203,344 | |
| Full year forecast | 2024/02/14 | 2,140,000 | 330,000 | – | 250,000 | – | |
| Full year revision | 2024/08/01 | 2,315,000 | 302,000 | – | 240,000 | – | |
| Full year revision | 2024/10/31 | 2,310,000 | 320,000 | – | 240,000 | – | |
| Full year revision | 2025/02/07 | 323,000 | – | – | 343,000 | – | |
| Full-year results | 2025/02/14 | 2,329,861 | 323,564 | – | 343,120 | 460,163 | |
Consolidated December 2025 | 2Q forecast | 2025/02/14 | 1,174,000 | 200,000 | – | 147,000 | – |
| Full year forecast | 2025/02/14 | 2,380,000 | 375,000 | – | 275,000 | – | |
| year | quarter | Submission date | sales revenue | Operating profit | Ordinary profit | Net income | Comprehensive income for the period |
![Medicinal hair growth agent [hair tonic glow gel]](https://companydata.tsujigawa.com/wp-content/uploads/2024/07/hair-tonic-glow-gel-pr-01-150x150.jpg)
